We are Clinicial Surveillance and Compliance. In September, we announced that our business will be called Clinical Surveillance & Compliance instead of Safety & Surveillance. Key drivers for this transition are the need to better clarify our solutions within the Health portfolio, and our business joining with Health Language to become the third business unit—Clinical Surveillance, Compliance & Data Solutions—in the division joining Health Learning, Research & Practice (HLRP) and Clinical Effectiveness (CE).
At the end of the day, these names are predominantly internal. To the outside world, our master brand remains Wolters Kluwer and we must work together across business units to represent our brand consistently; you’ll see small changes like the logo on the front door of our office, to larger initiatives like the OneWeb initiative that’s underway for 2020. With this focus of defining ‘who we are’ in mind, Health division leadership came together in September in New York to develop a shared mission. Watch the video to learn more.
We share a common mission with other business units within the Health division. In this video, Karen Kobelski, GM, Clinical Surveillance, Compliance & Data Solutions talks about our focus to ensure every patient benefits from the best knowledge and evidence to improve their care.
We’re delivering innovative solutions and features in our R4 release that is coming up on November 20 (the date was pushed back from October to accommodate this larger release). Our team is committed to helping clinicians stay in front of new and emerging clinical challenges with these updates—most of which will be showcased at ASHP Midyear in December:
Gathering feedback on our customers’ experience with our solution and exploring their evolving needs and expectations of how the solution should function are key insights our team needs to stay competitive in the marketplace. It’s also great for collecting testimonials to use through our sales and marketing efforts.
The Compliance team recently interviewed Matt Wolfe, System Coordinator Pharmacy Operations for Froedtert Hospital System in Milwaukee—we like what he had to say: “We place very high value on Simplifi 797. We recently survived a Joint Commission inspection and the inspectors asked to see Simplifi 797, asking us to show our completed activities. It was very easy to run the reports right out of Simplifi 797. It’s a tool that everyone touches on a daily basis, which makes it very important for our department.”
Sentri7 is improving patient care and improving hospital financial performance. We sat down with Matt Baldwin, Executive Director of Pharmacy at Aultman Hospital in Ohio to learn more about how his team is using Sentri7 to improve performance and drive cost savings. Here’s what he had to say:
“Sentri7 has also given us the ability to manage our larger target clinical initiatives like anticoagulation monitoring or AMS, as well as tailor our own rules as necessary, which gives us a lot of flexibility and control. We’ve seen a reduction of about $2 million in AMS spend alone since the inception of the program, as well as better patient outcomes. We’re looking to Sentri7 to support our future initiatives in the areas of opioid management and diabetes. We now know what’s possible in the solution and we’re asking ourselves ‘what else can we do?’”
The ongoing focus on POC Advisor integration and successful implementation of our customers remains a key focus for our leadership team. Watch the videos (right) to learn more about the importance of effective change management and how we’re applying this to Baton Rouge and Mosaic. Other key updates:
In the video above, Dr. Steve Claypool gives a brief update on what’s happening at Mosaic Life Care and Baton Rouge General.
Effective change management is a necessary for every POC Advisor solution implementation. In this video, Steve Claypool, M.D. talks about why.
USP enforcement of chapter <797> may be delayed per an announcement from USP in early September, but we’re moving forward and encouraging customers to do the same. Our partner, Eric S. Kastango (Kastango Consulting Group and CriticalPoint) MBA, BSPharm, FASHP, reminded us why it’s important that we all keep moving forward, “While these regulations are temporarily on hold, 797 (2008) and 795 (2014) versions will be enforced by state boards of pharmacy, the FDA and the Joint Commission. It’s so much more than about passing an inspection—it all boils down to keeping patients and staff safe. That is the priority.” We couldn’t agree more. With Simplifi 797®, our customers can be confident they have the tools, tasks and training to keep staff and patients safe and avoid costly penalties.
Fostering strong partnerships to strengthen our solutions and expand into adjacent markets is a key focus as we grow in 2020 and beyond. A few updates include:
The marketing and sales teams are also working with Omnicell as we prepare for ASHP Midyear in December—with our booths adjacent from each other, we have a great opportunity to tell the story of why we’re better together for improving compounding compliance for customers and prospects.
Top 3 Wins from the Past Quarter
Despite the rain, teams at the Summer Olympics shined! Our teams burned off some steam at the office’s annual Summer Olympics in September. “The Summer Olympics is a great annual event that offers friendly competition and a chance to mingle with co-workers from other teams,” said Nora Priske, Application Specialist II. Check out the photos below to see how the teams stayed upright during the Ski-walk, went a little deeper with the Limbo and tossed a few water balloons to earn points to win! The 2019 Summer Olympics crowning champion—the team that role-modeled that ‘we are stronger together’, living up to Wolters Kluwer value ‘win as a team’—was Team Turquoise! Kudos to: Allison Errickson, Saravana Muppuru, Alex Han, Brian Tortorice, Dustin School, Jeff Drengler, Mike Lucas, Sarah Strawn, Anna Nikolich, and JJ Chritton! More photos: R:\Employee Photos\Summer Olympics 2019
Take 5 minutes this week to shine a spotlight on some awesomeness! Kudos to the Star VIPs from the past quarter. The following individuals from Clinical Surveillance & Compliance have received nominations and thank you notes via the STAR VIP recognition program during the months of July, August, and September.
Star VIP – Tier 1 “Thank You” Recipient
Link To Thank You
Joshua Michaels, Tom Kazmerzak, Ian Emmons
Elaine Cizma, Cole Schenck
Tier 2 Nominees (Eligible for Quarterly Prize and Recognition)
Sarah Strawn, Justin Flechsig,
Jay Abushhiwa, Tina Reis, Mary Torgerson, Tom Jordan, Dana Ward, and Stephanie Locher
Peter Nash, Anna Nikolich,
Mitch Abaza, Wes Nevans, Dan Kaufman, Mykhailo Samorokov, Cheng Thao, and Jared Nichols
Elaine Cizma, Rachel Pelletier,
Sarah Strawn, Jeff Drengler, and Dan Delaney
Ian Emmons, Mike Dunk, JJ Chritton,
and Kang Liu
Brian Tortorice and Jay Abushhiwa
Drew Kiefer, Tom Kazmerzak,
Ryan Peterson, and Derek Woolley
Mike Dunk, JJ Chritton, Marla Albitz, Ian Emmons, James Jackson, Jim Martino, Sravan Muppuru, Naveen Bandreddi, Kang Liu, and Mackenzie Weise
This month we’re focusing on branding! Each month, our leadership team will answer the questions you have about our overall goals, projects or anything else that might be on your mind. If you have a question, submit it anonymously here.
Q. Why did Safety & Surveillance change to Clinical Surveillance & Compliance?
Safety & Surveillance was not the right name for our business. Our solutions are not ‘Safety’ solutions in a clinical setting, and some teams avoided using that term completely even though it’s used minimally externally. That’s why our leadership team decided to make the change now—it’s a chance to better define our solutions within the Health portfolio.
Q. Who should I say that I work for?
Your employer and master brand name is Wolters Kluwer. You work in the Health division of Wolters Kluwer for the Clinical Surveillance, Compliance & Data Solutions business unit. Your ‘business’ within that unit is Clinical Surveillance & Compliance.
Q. Why are you calling it Clinical Surveillance versus Pharmacy Surveillance—which sometimes resonates more with our customers?
With the addition of POC Advisor to our surveillance portfolio, we no longer have pharmacy-only surveillance solutions. Moving beyond the department ‘sale’ is equally important as we evolve our go-to-market strategy to target the hospital C-suite and Clinical Surveillance meets that need.
Q. Safety & Surveillance is referenced in so many places, what’s the plan for making the change to Clinical Surveillance & Compliance?
First of all, this is not going to happen overnight. As a first step, teams should identify where they need to make a change based on this announcement. If you are not sure about what you should say, please contact Marketing (Teresa.firstname.lastname@example.org)
Do you have an idea for features for next quarter’s newsletter? Submit it to email: Teresa.Westrich@wolterskluwer.com and include the subject: Newsletter idea.
Have a burning question you need answered via the quarterly Watercooler? Submit it via this form.
Written for clinicians